Digital Diagnostics Inc. is a pioneering AI diagnostics company that is revolutionizing global healthcare by utilizing technology to improve the accessibility, affordability, equity, and quality of medical diagnosis and treatment. Their mission is to benefit patients by transforming the healthcare industry through the application of innovative AI platforms. With a commitment to ethical AI healthcare, Digital Diagnostics develops autonomous diagnostic systems that increase patient access to early disease detection, aligning their algorithms with clinical practice guidelines and ensuring transparency in the decision-making process.
As the world leader in developing safe, effective, and equitable AI platforms, Digital Diagnostics' flagship product, LumineticsCore, is an autonomous AI diagnostic system that diagnoses patients for diabetic retinopathy, including macular edema. Cleared by the FDA, LumineticsCore has demonstrated high performance in real-world clinical settings, helping healthcare providers prevent vision loss from diabetes and improve patient outcomes. With cutting-edge technology and a focus on transforming care and access for patients, Digital Diagnostics is at the forefront of revolutionizing the healthcare industry.
Generated from the website